Effects of butylated hydroxyanisole and dicoumarol on the toxicity of menadione to rats

Chemico-Biological Interactions

Volumn 108, Issue 3, 1998, Pages 155-170

  Munday, Rex ^a   Smith, Barry L ^a   Munday, Christine M ^a  

^a RUAKURA RESEARCH CENTRE   (New Zealand)

Author keywords

Butylated hydroxyanisole; Dicoumarol; DT diaphorase; Menadione; Naphthoquinone toxicity; Toxicity in vivo

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BUTYLATED HYDROXYANISOLE; DICOUMAROL; HEMOGLOBIN; LACTATE DEHYDROGENASE; MENADIONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEMOLYTIC ANEMIA; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; TOXICITY;

ANEMIA, HEMOLYTIC; ANIMALS; ANTIOXIDANTS; BUTYLATED HYDROXYANISOLE; DICUMAROL; DIHYDROLIPOAMIDE DEHYDROGENASE; ENZYME INHIBITORS; ERYTHROCYTES; FEMALE; HEINZ BODIES; HEMOLYSIS; HEMOSTATICS; LIVER; NAD(P)H DEHYDROGENASE (QUINONE); ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; VITAMIN K;

ANIMALIA;

EID: 0032579441     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00105-1     Document Type: Article

References (66)

1. Gasser C. Heinz body anemia and related phenomena. J. Pediatr. 54:1959;673-690.
2. 3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc. Natl. Acad. Sci. USA. 81:1984;3529-3533.
3. 10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology. 43:1993;884-890.
4. 1 oxidoreductase (Complex I) deficiency: variable expression and possible treatment. J. Inherit. Metab. Dis. 12(2):1989;349-351.
5. Margolin K.A., Akman S.A., Leong L.A. et al. Phase I study of mitomycin c and menadione in advanced solid tumours. Cancer Chemother. Pharmacol. 36:1995;293-298.
6. 3 pretreatment in a mouse tumor resistant to oncovin. Anticancer Res. 12:1992;1651-1654.
7. Tetef M., Margolin K., Ahn C. et al. Mitomycin c and menadione for the treatment of lung cancer: a phase II trial. Invest. New Drugs. 13:1995;157-162.
8. 3 and methotrexate in tumor-bearing animals. Cancer Treat. Rep. 70:1986;1433-1435.
9. Tetef M., Margolin K., Ahn C. et al. Mitomycin c and menadione for the treatment of advanced gastrointestinal cancers: a phase II trial. J. Cancer Res. Clin. Oncol. 121:1995;103-106.
10. Chlebowski R.T., Akman S.A., Block J.B. Vitamin K in the treatment of cancer. Cancer Treat. Rev. 12:1985;49-63.
11. Chlebowski R.T., Block J.B., Dietrich M. et al. Inhibition of human tumor growth and DNA biosynthetic activity by vitamin K and Warfarin: in vitro and clinical results. Proc. Am. Assoc. Cancer Res. 24:1983;165.
12. O'Brien P.J. Molecular mechanisms of quinone cytotoxicity. Chem.-Biol. Interact. 80:1991;1-41.
13. Powis G. Metabolism and reactions of quinoid anticancer agents. Pharmacol. Ther. 35:1987;57-162.
14. Smith M.T., Evans C.G., Thor H., Orrenius S. Quinone-induced oxidative injury to cells and tissues. Sies H. Oxidative Stress. 1985;91-113 Academic Press, London.
15. Kiese M. Methemoglobinemia: a comprehensive treatise. 1974;CRC Press, Cleveland, OH.
16. Hatton E.H., Dodds A., Hodge H.C., Fosdick L.S. The effect of prolonged ingestion of synthetic vitamin K in rats. J. Dent. Res. 24:1945;283-295.
17. 1, phthiocol and 2-methyl-1,4-naphthoquinone. Proc. Soc. Exp. Biol. Med. 43:1940;125-128.
18. 3 (menadione) especially on the development of experimental splenomegaly. Gunma J. Med. Sci. 8:1959;357-371.
19. Munday R., Fowke E.A., Smith B.L., Munday C.M. Comparative toxicity of alkyl-1,4-naphthoquinones in rats: relationship to free radical production in vitro. Free Radic. Biol. Med. 16:1994;725-731.
20. Fernandez F.R., Davies A.P., Teachout D.J., Krake A., Christopher M.M., Perman V. Vitamin K-induced Heinz body formation in dogs. J. Am. Anim. Hosp. Assoc. 20:1984;711-720.
21. Richards R.K., Shapiro S. Experimental and clinical studies on the action of high doses of hykinone and other menadione derivatives. J. Pharmacol. Exp. Ther. 84:1945;93-104.
22. Ansbacher S., Corwin W.C., Thomas B.G.H. Toxicity of menadione, menadiol and esters. J. Pharmacol. Exp. Ther. 75:1942;111-124.
23. Andaya A.A., Di Giulio R.T. Acute toxicities and hematological effects of two substituted naphthoquinones in channel catfish. Arch. Environ. Contam. Toxicol. 16:1987;233-238.
24. Butler J., Hoey B.M. The apparent inhibition of superoxide dismutase activity by quinones. J. Free Radic. Biol. Med. 2:1986;77-81.
25. Meisel D., Czapski G. One-electron transfer equilibria and redox potentials of radicals studied by pulse radiolysis. J. Phys. Chem. 79:1975;1503-1509.
26. Powis G., Svingen B.A., Appel P. Quinone-stimulated superoxide formation by subcellular fractions, isolated hepatocytes and other cells. Mol. Pharmacol. 20:1981;387-394.
27. Chesis P.L., Levin D.E., Smith M.T., Ernster L., Ames B.N. Mutagenicity of quinones: pathways of metabolic activation and detoxification. Proc. Natl. Acad. Sci. USA. 81:1984;1696-1700.
28. Iyanagi T. On the mechanisms of 1- and 2-electron transfer by flavin enzymes. Chem. Script. 27A:1987;31-36.
29. Goldberg B., Stern A. Production of superoxide anion during the oxidation of hemoglobin by menadione. Biochim. Biophys. Acta. 437:1976;628-632.
30. Thor H., Smith M.T., Hartzell P., Bellomo G., Jewell S.A., Orrenius S. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. J. Biol. Chem. 257:1982;12419-12425.
31. Munday R. Autoxidation of naphthohydroquinones: effects of metals, chelating agents and superoxide dismutase. Free Radic. Biol. Med. 22:1997;689-695.
32. Munday R. Inhibition of naphthohydroquinone autoxidation by DT-diaphorase (NAD(P)H:[quinone acceptor] oxidoreductase). Redox Rep. 3:1997;189-196.
33. Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem. Pharmacol. 49:1995;127-140.
34. 14C]menadione. Biochemistry. 6:1967;62-68.
35. Ernster L., Danielson L., Ljunggren M. DT-Diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm and properties. Biochim. Biophys. Acta. 58:1962;171-188.
36. Ernster L. DT-diaphorase: a historical review. Chem. Script. 27A:1987;1-13.
37. Djuric Z., Corbett T.H., Valeriote F.A., Heilbrun L.K., Baker L.H. Detoxification ability and toxicity of quinones in mouse and human tumor cell lines used for anticancer drug screening. Cancer Chemother. Pharmacol. 36:1995;20-26.
38. Hollander P.M., Ernster L. Studies on the reaction mechanism of DT-diaphorase. Action of dead-end inhibitors and effects of phospholipids. Arch. Biochem. Biophys. 169:1975;560-567.
39. Morrison H., Jernstrom B., Nordenskjold M., Thor H., Orrenius S. Induction of DNA damage by menadione (2-methyl-1,4-naphthoquinone) in primary cultures of rat hepatocytes. Biochem. Pharmacol. 33:1984;1763-1769.
40. Utley W.S., Mehendale H.M. Phenobarbital-induced cytoprotective mechanisms in menadione metabolism: the role of glutathione reductase and DT-diaphorase. Int. J. Biochem. 22:1990;957-967.
41. Powis G., See K.L., Santone K.S., Melder D.C., Hodnett E.M. Quinoneimines as substrates for quinone reductase (NAD(P)H:(quinone-acceptor) oxidoreductase) and the effect of dicumarol on their cytotoxicity. Biochem. Pharmacol. 36:1987;2473-2479.
42. Parola M., Cheeseman K.H., Biocca M.E., Dianzani M.U., Slater T.F. Menadione and cumene hydroperoxide induced cytotoxicity in biliary epithelial cells isolated from rat liver. Biochem. Pharmacol. 39:1990;1727-1734.
43. Tzeng W-F., Chiou T-J., Wang C-P., Lee J-L., Chen Y-H. Cellular thiols as a determinant of responsiveness to menadione in cardiomyocytes. J. Mol. Cell. Cardiol. 26:1994;889-897.
44. Flowers-Geary L., Harvey R.G., Penning T.M. Cytotoxicity of polycyclic aromatic hydrocarbon o-quinones in rat and human hepatoma cells. Chem. Res. Toxicol. 6:1993;252-260.
45. Atallah A.S., Landolph J.R., Ernster L., Hochstein P. DT-diaphorase activity and the cytotoxicity of quinones in C3H/l0T1/2 mouse embryo cells. Biochem. Pharmacol. 37:1988;2451-2459.
46. Tsuda H. Role of DT-diaphorase the cytotoxicity of menadione and 4-nitroquinoline-1 oxide in cultured mammalian fibroblastic cells. Cancer Lett. 55:1990;195-199.
47. D'Odorico A., Sturniolo G.C., Bilton R.F., Morris A.I., Gilmore I.T., Naccarato R. Quinone-induced DNA single strand breaks in a human colon carcinoma cell line. Carcinogenesis. 18:1997;43-46.
48. Benson A.M., Hunkeler M.J., Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA. 77:1980;5216-5220.
49. Prochaska H.J., Talalay P., Sies H. Direct protective effect of NAD(P)H:quinone reductase against menadione-induced chemiluminescence of postmitochondrial fractions of mouse liver. J. Biol. Chem. 262:1987;1931-1934.
50. Wefers H., Komai T., Talalay P., Sies H. Protection against reactive oxygen species by NAD(P)H: quinone reductase induced by the dietary antioxidant butylated hydroxyanisole (BHA). Decreased hepatic low-level chemiluminescence during quinone redox cycling. FEBS Lett. 169:1984;63-66.
51. Liu R-M., Sainsbury M., Tabor M.W., Shertzer H.G. Mechanisms of protection from menadione toxicity by 5,10-dihydroindeno[1,2-b]indole in a sensitive and resistant mouse hepatocyte line. Biochem. Pharmacol. 46:1993;1491-1499.
52. Martins E.A.L., Mori L., Birnboim H.C., Meneghini R. Menadione-resistant Chinese hamster cell variants are cross-resistant to hydrogen peroxide and exhibit stable chromosomal and biochemical alterations. Mol. Cell. Biochem. 118:1992;181-189.
53. Evelyn K.A., Malloy H.T. Microdetermination of oxyhemoglobin, methemoglobin and sulfhemoglobin in a single sample of blood. J. Biol. Chem. 126:1938;655-662.
54. Winterbourn C.C. Protection by ascorbate against acetylphenylhydrazine-induced Heinz body formation in glucose-6-phosphate dehydrogenase deficient erythrocytes. Br. J. Haematol. 41:1979;245-252.
55. Schor N.A., Boh E., Burke V.T. Carcinogens and dicumarol: opposite effects on rat liver NAD(P)H dehydrogenation. Enzyme. 23:1978;217-224.
56. Rose C.L., Harris P.N., Chen K.K. Toxicity of 3,3′- methylenebis (4-hydroxycoumarin). Proc. Soc. Exp. Biol. Med. 50:1942;228-232.
57. Paolucci A.M., Rama Rao P.B., Johnson B.C. Vitamin K deficiency and oxidative phosphorylation. J. Nutr. 81:1963;17-22.
58. Reinhart W.H., Sung L.A., Chien S. Quantitative relationship between Heinz body formation and red blood cell deformability. Blood. 68:1986;1376-1383.
59. Palek J., Lux S.E. Red cell membrane skeletal defects in hereditary and acquired hemolytic anemias. Semin. Hematol. 20:1983;189-224.
60. Low P.S. Structure and function of the cytoplasmic domain of band 3: center of erythrocyte membrane-peripheral protein interactions. Biochim. Biophys. Acta. 864:1986;145-167.
61. Cha Y-N., Heine H.S. Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats. Cancer Res. 42:1982;2609-2615.
62. Buetler T.M., Gallagher E.P., Wang C., Stahl D.L., Hayes J.D., Eaton D.L. Induction of phase I and phase II drug-metabolising enzyme mRNA, protein and activity by BHA, ethoxyquin and oltipraz. Toxicol. Appl. Pharmacol. 135:1995;45-57.
63. Lind C., Vadi H., Ernster L. Metabolism of benzo(a)pyrene-3,6-quinone and 3-hydroxybenzo(a)pyrene in liver microsomes from 3-methylcholanthrene-treated rats. Arch. Biochem. Biophys. 190:1978;97-108.
64. Benson A.M., Barretto P.B., Stanley J.S. Induction of DT-diaphorase by anticarcinogenic sulfur compounds in mice. J. Nat. Cancer Inst. 76:1986;467-473.
65. Spencer S.R., Wilczak C.A., Talalay P. Induction of glutathione transferases and NAD(P)H: quinone reductase by fumaric acid derivatives in rodent cells and tissues. Cancer Res. 50:1990;7871-7875.
66. 1 (phylloquinone) in man. Biochem. Med. 24:1980;250-267.